Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimising systemic activity (vol 6, pg 137, 2013)

被引：0
|
作者：
Prantera, C. [1 ]
Marconi, Stefano [1 ]
机构：
[1] Chiesi Farmaceutici SpA, Parma, Italy
来源：
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY | 2013年 / 6卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [31] Erythrocyte activity of TPMT and treatment with thiopurines in inflammatory bowel disease
    Morral, ED
    Duro, MAG
    MEDICINA CLINICA, 2005, 125 (08): : 293 - 294
  • [32] MR colonography in inflammatory bowel disease (vol 31, pg 302, 2006)
    Schreyer, A. G.
    Scheibl, K.
    Heiss, P.
    Feuerbach, S.
    Seitz, J.
    Herfarth, H.
    ABDOMINAL IMAGING, 2014, 39 (03): : 673 - 673
  • [33] Infliximab in paediatric inflammatory bowel disease (vol 1, pg 2, 2007)
    Vilar, P.
    JOURNAL OF CROHNS & COLITIS, 2008, 2 (02): : 189 - 189
  • [34] Drug therapy - Inflammatory bowel disease (vol 334, pg 841, 1996)
    Hanauer, SB
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02): : 143 - 143
  • [35] Immunopathology of human inflammatory bowel disease (vol 18, pg 555, 1997)
    Brandtzaeg, P
    Haraldsen, G
    Rugtveit, J
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 1997, 19 (02): : 269 - 269
  • [36] Systemic glutathione peroxidase activity is reduced in patients with inflammatory bowel disease (IBD).
    Reimund, JM
    Hirth, C
    Koehl, C
    Baumann, R
    Duclos, B
    GASTROENTEROLOGY, 1997, 112 (04) : A1069 - A1069
  • [37] Products for the treatment of inflammatory bowel disease: a patent review (2013-2014)
    Di Stasi, Luiz C.
    Costa, Celso A. R. A.
    Witaicenis, Aline
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2015, 25 (06) : 629 - 642
  • [38] Systemic treatment of patients who have colorectal cancer and inflammatory bowel disease
    Goessling, Wolfram
    Mayer, Robert J.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (03) : 713 - +
  • [39] EFFICACY OF 6-MERCAPTOPURINE IN THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    HINOJOSA, J
    MOLES, JR
    NOS, P
    HOYOS, M
    RAMIREZ, JJ
    PRIMO, J
    FERNANDEZ, J
    BERENGUER, JY
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 1995, 87 (11) : 775 - 780
  • [40] JAK inhibitors: Current position in treatment strategies for use in inflammatory bowel disease (vol 55, pg 99, 2020)
    Hernandez-Rocha, Cristian
    Vande Casteele, Niels
    CURRENT OPINION IN PHARMACOLOGY, 2021, 58 : 68 - 68
12345